These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2792900)

  • 1. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
    Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
    Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
    Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
    Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
    Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
    Gynecol Oncol; 1990 Jun; 37(3):319-22. PubMed ID: 2190870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of serum 125Ca levels: does the result preclude second look?
    Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM
    Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation.
    Mogensen O; Mogensen B; Jakobsen A; Sell A
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1835-7. PubMed ID: 3220081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1992 Jun; 45(3):323-8. PubMed ID: 1612511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
    Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
    J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
    Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
    Gynecol Oncol; 1990 Sep; 38(3):373-6. PubMed ID: 2227551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
    Rose PG; Terrien JM; Baker S
    J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.
    Gallion HH; Hunter JE; van Nagell JR; Averette HE; Cain JM; Copeland LJ; Higgins RV; Husseinzadeh N; Nahhas WA; Partridge EE
    Gynecol Oncol; 1992 Jul; 46(1):29-32. PubMed ID: 1634137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
    Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
    Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between serum CA125 level and second-look findings in ovarian cancers].
    Liu LY
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):287-9. PubMed ID: 1327702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers of epithelial and stromal cell origin at second-look laparotomy in ovarian carcinoma.
    Tomás C; Kauppila A
    Gynecol Oncol; 1992 Jun; 45(3):279-83. PubMed ID: 1612504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 125 surveillance and second-look laparotomy in ovarian carcinoma.
    Atack DB; Nisker JA; Allen HH; Tustanoff ER; Levin L
    Am J Obstet Gynecol; 1986 Feb; 154(2):287-9. PubMed ID: 3456202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA-125 in gynecological malignancies.
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of second-look laparotomy for ovarian cancer: second-look vs. serum CA125.
    Liu L; Hong W; Hou Y; Yao Z; Wu A; Wang X
    Chin Med Sci J; 1991 Jun; 6(2):96-9. PubMed ID: 1804384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of CA-125 levels in advanced ovarian cancer.
    Patsner B; Day TG
    Am J Obstet Gynecol; 1987 Feb; 156(2):440-1. PubMed ID: 3469916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 125 serum levels correlated with second-look operations among ovarian cancer patients.
    Berek JS; Knapp RC; Malkasian GD; Lavin PT; Whitney C; Niloff JM; Bast RC
    Obstet Gynecol; 1986 May; 67(5):685-9. PubMed ID: 3457330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings].
    Meden H; Rath W; Teichmann A; Kuhn W
    Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.